| Identification | More | [Name]
2,6-Dibromotoluene | [CAS]
69321-60-4 | [Synonyms]
2,6-DIBROMOTOLUENE
1,3-Dibromo-2-methylbenzene
Benzene, 1,3-dibromo-2-methyl-
2,6-Dibromotoluene, 98+% | [EINECS(EC#)]
250-689-9 | [Molecular Formula]
C7H6Br2 | [MDL Number]
MFCD00013524 | [Molecular Weight]
249.93 | [MOL File]
69321-60-4.mol |
| Safety Data | Back Directory | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [HS Code ]
29039990 |
| Hazard Information | Back Directory | [Chemical Properties]
Colorless liquid | [Preparation]
2,6-Dibromotoluene is an important pharmaceutical intermediate，It can be made from toluene using sulfonation and desulfonation as intermediate steps in the synthesis. |
| Questions And Answer | Back Directory | [Application]
2,6-Dibromobenzyl bromide is an important pharmaceutical intermediate. Leukotrienes and prostaglandins are important mediators of inflammation and can promote the development of inflammation through different pathways. The cytosolic phospholipase (cPLA2) synthesized from 2,6-dibromobenzyl bromide in patent WO2006128142A2 can act as a chemical inhibitor of leukotriene and prostaglandin activity, thereby achieving the effect of treating inflammation. |
|
|